MADRID (AP) – Desperate to finally put an end to the coronavirus epidemic, thousands of Spaniards lined up to receive footage of AstraZeneca on Wednesday as the European country became the last to restart a vaccine whose credibility has recently suffered a number of setbacks.
Like neighboring countries that have stopped using the vaccine to study possible side effects, Spanish health officials are now trying to restore confidence in the shot, which is currently one in three in the European Union. This is especially true as many countries on the continent struggle to increase vaccinations slowly until they see an increase in infections again.
The core of Spain’s AstraZeneca returns just one day after another blow to its reputation, when US officials said the British-Swedish pharmaceutical company could include “outdated information” about the effectiveness of its COVID-19 vaccine in US tests.
It was not the first slip of the bat, which is cheaper, easier to maintain than many of its competitors, and was therefore expected to be widely used around the world, especially in poorer countries. The company has previously had questions about its data transmission, with more than a dozen European countries recently shutting down the message of rare blood clots to some recipients. The European Medicines Agency said last week that the vaccine did not increase the overall risk of coagulation.
Still, experts fear that repeated negative attention to the vaccine could undermine confidence in it, even in the immunization program in general, at a time when the coronavirus is growing again on the continent.
As in other countries, there have been reports of cancellation of vaccine prescriptions in some Italian regions, but the phenomenon seems to be unequal. Norway has expressed concern over the high level of rejection of the shot.
But so far, in Spain, the fear of being in the intensive care unit, or worse, seems to falsify all the concerns people have about the vaccine.
Belen Ruiz, 56, who works with children with disabilities, was the 5,000 people who were assigned to take a shot at Madrid’s Wanda Metropolitano Stadium on Wednesday. He said he was a little anxious as he waited in a long line, in part because he had previously dealt with blood tissue.
“No one put a gun to my head, but I feel half-obliged to take it. In the workplace, I am constantly at risk; I communicate with people who are at risk. And there is all this social pressure, even from my colleagues, not to be the only ones who refuse the vaccine, ”said Ruiz, who lost his 88-year-old father to COVID-19 last year.
After eight days of discontinuation of AstraZeneca, more than 900,000 doses are collected in Spain, almost equal to the number of shots already fired. Due to fears about its effectiveness among older people, Spain uses AstraZeneca only on key employees under 65. Even that reflects the recent mitigation. It was originally only allowed for people under the age of 55.
At the same time, it has handled 5 million images of Pfizer-BioNTech և 355,000 Moderna seniors.
Spain այլ Other European countries have the luxury of that choice, but they still need AstraZeneca to achieve their goals. And many are sadly left behind. For example, recent data show that less than 14% of people in the EU have had at least one stroke, compared with 45% in the UK and 38% in the US.
Authorities in Catalonia in northeastern Spain said 87% of the bets offered on Wednesday had been taken away by 14,000 people, with many of those who turned them down registering in the coming days.
In Italy, Veneto Governor Luca Zaia said this week that teachers in the Northeast, with a population of 5 million, had made many of the banned exhibitions, with some day cancellations making up half the appointments. But he said the phenomenon was easing.
“Objectively, we have an unacceptably high level,” Za ayan said on Italian television on Tuesday.
Following reports that AstraZeneca has stopped using some restrictions in Croatia in recent days, Prime Minister Andrej Plenkoviև and his Minister of Health stepped forward on Wednesday to film.
In the UK, where AstraZeneca is the backbone of its strong spread, there are some signs of suspicion: և Hundreds of shots of the vaccine or Pfizer-BioNTech are delivered every day.
Other countries are even more dependent on AstraZeneca, the backbone of COVAX, which aims to provide vaccines to low- and middle-income countries.
In the Kenyan town of Machakos, Ra Uliana Mvendu, AstraZeneca’s staff nurse, said more patients were coming in after terrible days.
“I have already given more than 50 people since the morning,” he said. “So I think now that they have confirmed that the vaccine is normal, people are positive about it now, they are really coming.”
But others, such as Steven Musyoka, a motorcycle taxi driver, remain reluctant to notice the concerns elsewhere.
“I hear there is a marriage vaccine,” said Musyoka, “but I և my family will not get it.”
Wilson reported from Barcelona, Spain. Kyle Kazzihan in Machakos, Kenya, Colin Barry in Milan, Italy, Dusan Stojanovic in Belgrade, Serbia.
Follow AP epidemic coverage https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine և https://apnews.com/Und UndingingtheOutbreak.